[HTML][HTML] Quetiapine treatment for post-traumatic stress disorder: a systematic review of the literature

C Crapanzano, S Damiani, I Casolaro… - Clinical …, 2023 - ncbi.nlm.nih.gov
Paroxetine and Sertraline are the only medications approved in posttraumatic stress
disorder (PTSD). However, about 60% of traumatized patients fail to show an adequate …

Dopamine partial agonists: a discrete class of antipsychotics

D Taylor, R Chithiramohan, J Grewal… - … Journal of Psychiatry …, 2023 - Taylor & Francis
Worldwide, there are now three marketed dopamine D2 partial agonists: aripiprazole,
brexpiprazole and cariprazine. These three drugs share a number of properties other than …

[HTML][HTML] Serotonin and dopamine depletion in distinct brain regions may cause anxiety in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated mice as a model of …

R Yang, S Ye, S Zhang, H Huang, Y Zhang, Y Yang… - …, 2023 - journals.lww.com
In this study, we aimed to evaluate the association of early anxious behavior with serotonin,
dopamine, and their metabolites in a 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) …

Antipsychotic agents in anxiety disorders: An umbrella review

A Garakani, FD Buono, M Salehi… - Acta Psychiatrica …, 2024 - Wiley Online Library
Background Although not approved for the treatment of anxiety disorders (except
trifluoperazine) there is ongoing off‐label, unapproved use of first‐generation antipsychotics …

Olanzapine for the treatment of somatic symptom disorder: biobehavioral processes and clinical implications

C Crapanzano, C Amendola, A Politano… - Psychosomatic …, 2022 - journals.lww.com
In everyday clinical practice, we are increasingly facing somatic symptoms and disorders as
a source of disability and suffering. In a recent issue of this journal, Toussaint et al.(1) …

[HTML][HTML] Efficacy of olanzapine in anxiety dimension of schizophrenia: a systematic review of randomized controlled trials

C Crapanzano, I Casolaro, S Damiani… - Clinical …, 2022 - ncbi.nlm.nih.gov
Anxiety symptoms and anxiety disorders are frequent in patients with schizophrenia and are
associated with greater severity of both positive and negative symptoms, cognitive …

A validated method for the determination of quetiapine fumarate tablets in human plasma by UPLC-MS/MS and its application to a pharmacokinetic study in healthy …

K Luo, H Zhao, H Zhang, L Huang… - Pakistan Journal of …, 2023 - search.ebscohost.com
A rapid, highly specific and sensitive UPLC-MS/MS method was developed for the
determination of Quetiapine Fumarate, a therapeutic drug for various psychiatric disorders …

Inhibition of HCN1 currents by norquetiapine, an active metabolite of the atypical anti-psychotic drug quetiapine

N D'Avanzo, AJ Jacques - Authorea Preprints, 2023 - essopenarchive.org
Background and Purpose Quetiapine is a second-generation atypical antipsychotic drug that
has been commonly prescribed for the treatment of schizophrenia, major depressive …

Role of Lithium in 2023 in Bipolar I Mania and Depression.

DN Osser - Psychiatric Times, 2023 - search.ebscohost.com
The article explores the function of lithium in the treatment of bipolar I mania and depression.
It cites some options for treating mixed mania and bipolar depressions such as quetiapine …

Anxiolytika

IG Anghelescu, O Benkert - Kompendium der Psychiatrischen …, 2023 - Springer
Zusammenfassung Indikationen, Wirkungsweise, Nebenwirkungen und Risiken,
Kontraindikationen und Interaktionen werden für die Anxiolytika im allgemeinen Teil und …